ORIX Corporation
IX Real Time Price USDRecent trades of IX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by IX's directors and management
Government lobbying spending instances
-
$20,000 Aug 24, 2017 Issue: Medicare/Medicaid
-
$30,000 Jul 20, 2017 Issue: Medicare/Medicaid
-
$30,000 Apr 20, 2017 Issue: Medicare/Medicaid
-
$30,000 Jan 19, 2017 Issue: Medicare/Medicaid
-
$10,000 Feb 07, 2008 Issue: Defense
-
$20,000 Mar 01, 2007 Issue: Defense
-
$30,000 Mar 01, 2006 Issue: Defense
-
$40,000 Aug 23, 2005 Issue: Defense
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of IX in WallStreetBets Daily Discussion
Recent insights relating to IX
Recent picks made for IX stock on CNBC
ETFs with the largest estimated holdings in IX
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view IX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.